Clinical Trial

Role of Cardiac AngioMR in Diagnosis of Cardiac and Vascular Anomalies in Adult Patients with Turner Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Considering the high prevalence of cardiovascular disease in Turner syndrome patients, noninvasive cardiac imaging is crucial for diagnosis and follow-up. From the review of the literature, it was evident that the imaging techniques used involved the evaluation of only the thoracic findings, in particular the heart and the thoracic aorta, while no data are currently available on the distal abdominal aorta or iliac arteries, since ultrasound and MRI are interrupted at the diaphragmatic level.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-11.
Trial Details
NCT Number NCT06178887
Lead Sponsor Azienda Ospedaliero-Universitaria di Modena
Conditions Anomaly Heart, Turner Syndrome
Enrollment 33 participants
Start Date 2019-01-08
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-14